I
Irene J Higginson
Researcher at King's College London
Publications - 855
Citations - 48422
Irene J Higginson is an academic researcher from King's College London. The author has contributed to research in topics: Palliative care & Health care. The author has an hindex of 101, co-authored 822 publications receiving 42141 citations. Previous affiliations of Irene J Higginson include University of London & St Thomas' Hospital.
Papers
More filters
Journal ArticleDOI
A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease
TL;DR: It was found that the prevalence of the 11 symptoms was often widely but homogeneously spread across the five diseases, and there appears to be a common pathway toward death for malignant and nonmalignant diseases.
Journal ArticleDOI
Factors influencing death at home in terminally ill patients with cancer: systematic review.
Barbara Gomes,Irene J Higginson +1 more
TL;DR: The relative influence of different factors on place of death in patients with cancer is determined to focus on ways of empowering families and public education, as well as intensifying home care, risk assessment, and training practitioners in end of life care.
Journal ArticleDOI
Measuring quality of life: Using quality of life measures in the clinical setting.
Irene J Higginson,Alison Carr +1 more
TL;DR: This article reviews the challenges of using quality of life measures in clinical practice including selecting appropriate measures, analysing data, providing feedback, interpreting results, and incorporating these measures into clinical decision making.
Journal ArticleDOI
Place of care in advanced cancer: a qualitative systematic literature review of patient preferences.
TL;DR: Home care is the most common preference, with inpatient hospice care as second preference in advanced illness, and study designs in this area need to be improved.
Journal ArticleDOI
The Prevalence of Symptoms in End-Stage Renal Disease: A Systematic Review
TL;DR: No evidence is available on symptom prevalence in ESRD patients managed conservatively (without dialysis), but evidence in patients discontinuing dialysis suggests they too have significant symptom burden.